Theracle
PrivateLast Round
VC Round
Oct 6, 2025
Company Overview
Theracle operates in Healthcare & Life Sciences and is based in Milpitas, California. Its latest recorded funding round was a VC Round in October 2025.
Theracle is a medical technology company developing an implantable drug-delivery platform designed to bypass the blood-brain barrier for the treatment of neurological conditions and brain cancers.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theracle Comparables
Compare Theracle with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cognos Therapeutics Inc | 86% | |
| CraniUS Therapeutics | 85% | |
| Carthera | 78% |
For institutional investors. Book with your work email.
Theracle Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 6, 2025
Raised a VC Round with participation from Neuroceuticals Inc.
- May 2, 2013
Accelerator round led by InCube Labs
For institutional investors. Book with your work email.
Theracle Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Theracle's valuation, stock price, and market status.
Is Theracle a public or private company?
Theracle is a private company.
What is the current stock price of Theracle?
Theracle is a private company, so its shares have no public market price. Caplight tracks Theracle's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Theracle worth (valuation)?
Valuation information for Theracle is not publicly available.
Can I buy Theracle stock?
Theracle shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Theracle's last funding round?
Theracle's most recent funding round was VC Round on October 6, 2025.
Who are the main investors in Theracle?
Investor information for Theracle is not publicly disclosed.
Will Theracle IPO soon?
No public IPO plans have been announced for Theracle.
How can I track Theracle secondary market activity?
Caplight tracks bids, offers, and trades in Theracle's shares on secondary markets.